|
1
|
Italiano JE, Patel-Hett S and Hartwig JH:
Mechanics of proplatelet elaboration. J Thromb Haemost. 5(Suppl 1):
S18–S23. 2007. View Article : Google Scholar
|
|
2
|
Bender M, Eckly A, Hartwig JH, Elvers M,
Pleines I, Gupta S, Krohne G, Jeanclos E, Gohla A, Gurniak C, et
al: ADF/n-cofilin-dependent actin turnover determines platelet
formation and sizing. Blood. 116:1767–1775. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ruggeri ZM: Platelets in atherothrombosis.
Nature Med. 8:1227–1234. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stoll G, Kleinschnitz C and Nieswandt B:
Molecular mechanisms of thrombus formation in ischemic stroke:
Novel insights and targets for treatment. Blood. 112:3555–3562.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schrör K: Antiplatelet drugs. A
comparative review. Drugs. 50:7–28. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ni H and Freedman J: Platelets in
hemostasis and thrombosis: Role of integrins and their ligands.
Transfus Apher Sci. 28:257–264. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Barrett NE, Holbrook L, Jones S, Kaiser
WJ, Moraes LA, Rana R, Sage T, Stanley RG, Tucker KL, Wright B and
Gibbins JM: Future innovations in anti-platelet therapies. Br J
Pharmacol. 154:918–939. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bird JE, Giancarli MR, Allegretto N,
Barbera F, Wong P, Schumacher WA, Ogletree ML and Seiffert D:
Prediction of the therapeutic index of marketed anti-coagulants and
anti-platelet agents by guinea pig models of thrombosis and
hemostasis. Thromb Res. 123:146–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Northeast AD, Soo KS, Bobrow LG, Gaffney
PJ and Burnand KG: The tissue plasminogen activator and urokinase
response in vivo during natural resolution of venous thrombus. J
Vasc Surg. 22:573–579. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Singh I, Burnand KG, Collins M, Luttun A,
Collen D, Boel-houwer B and Smith A: Failure of thrombus to resolve
in urokinase-type plasminogen activator gene-knockout mice: Rescue
by normal bone marrow-derived cells. Circulation. 107:869–875.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gossage JA, Humphries J, Modarai B,
Burnand KG and Smith A: Adenoviral urokinase-type plasminogen
activator (uPA) gene transfer enhances venous thrombus resolution.
J Vasc Surg. 44:1085–1090. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aguirre Ghiso JA, Alonso DF, Farías EF,
Gomez DE and Bal de Kier Joffè E: Deregulation of the signaling
pathways controlling urokinase production. Its relationship with
the invasive phenotype. Eur J Biochem. 263:295–304. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blasi F and Carmeliet P: uPAR: A versatile
signalling orchestrator. Nat Rev Mol Cell Biol. 3:932–943. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee KH, Hyun MS and Kim JR: Growth
factor-dependent activation of the MAPK pathway in human pancreatic
cancer: MEK/ERK and p38 MAP kinase interaction in uPA synthesis.
Clin Exp Metastasis. 20:499–505. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu SQ, Huang JA, Qin MB, Su YJ, Lai MY,
Jiang HX and Tang GD: Sphingosine kinase 1 enhances colon cancer
cell proliferation and invasion by upregulating the production of
MMP-2/9 and uPA via MAPK pathways. Int J Colorectal Dis.
27:1569–1578. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Benasciutti E, Pagès G, Kenzior O, Folk W,
Blasi F and Crippa MP: MAPK and JNK transduction pathways can
phosphorylate Sp1 to activate the uPA minimal promoter element and
endogenous gene transcription. Blood. 104:256–262. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nizamutdinova IT, Jin YC, Kim JS, Yean MH,
Kang SS, Kim YS, Lee JH, Seo HG, Kim HJ and Chang KC: Paeonol and
paeoniflorin, the main active principles of Paeonia albiflora,
protect the heart from myocardial ischemia/reperfusion injury in
rats. Planta medica. 74:14–18. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo RB, Wang GF, Zhao AP, Gu J, Sun XL and
Hu G: Paeoni-florin protects against ischemia-induced brain damages
in rats via inhibiting MAPKs/NF-κB-mediated inflammatory responses.
PLoS One. 7:e497012012. View Article : Google Scholar
|
|
19
|
National Research Council: Guide for the
Care and Use of Laboratory Animals. 8th edition. National Academies
Press: Washington, D.C; 1996
|
|
20
|
Miner J and Hoffhines A: The discovery of
aspirin's antithrombotic effects. Tex Heart Inst J. 34:179–186.
2007.PubMed/NCBI
|
|
21
|
Lijnen HR: Matrix metalloproteinases and
cellular fibrinolytic activity. Biochemistry (Mosc). 67:92–98.
2002. View Article : Google Scholar
|
|
22
|
Burnand KG, Gaffney PJ, McGuinness CL,
Humphries J, Quarmby JW and Smith A: The role of the monocyte in
the generation and dissolution of arterial and venous thrombi.
Cardiovasc Surg. 6:119–125. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye J, Duan H, Yang X, Yan W and Zheng X:
Anti-thrombosis effect of paeoniflorin: Evaluated in a
photochemical reaction thrombosis model in vivo. Planta Med.
67:766–767. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Yoshida A, Nakao S, Kobayashi M and
Kobayashi H: Flow-mediated vasodilation and plasma fibronectin
levels in preeclampsia. Hypertension. 36:400–404. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pulkkinen MO, Lehto M, Jalkanen M and
Näntö-Salonen K: Collagen types and fibronectin in the uterine
muscle of normal and hypertensive pregnant patients. Am J Obstet
Gynecol. 149:711–717. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lowe GD and Rumley A: Use of fibrinogen
and fibrin D-dimer in prediction of arterial thrombotic events.
Thromb Haemost. 82:667–672. 1999.PubMed/NCBI
|
|
27
|
Bowen RS, Zhang Y, Gu Y, Lewis DF and Wang
Y: Increased phospholipase A2 and thromboxane but not prostacyclin
production by placental trophoblast cells from normal and
preeclamptic pregnancies cultured under hypoxia condition.
Placenta. 26:402–409. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao S, Gu Y, Lewis DF and Wang Y:
Predominant basal directional release of thromboxane, but not
prostacyclin, by placental trophoblasts from normal and
preeclamptic pregnancies. Placenta. 29:81–88. 2008. View Article : Google Scholar
|
